Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q2

3055.TEDINET S100S5VW
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥135.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥262.6bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥129.7bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.1bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.4bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥3.9bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥2.1bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥730m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥730m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥1.4bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥147.6bnat 2023-09-30Cons.Assets
Total assets¥137.9bnat 2023-03-31Cons.Assets
Total assets¥140.6bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥88.9bnat 2023-09-30Cons.Liabilities
Total liabilities¥80.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥58.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥57.4bnat 2023-03-31Cons.Net assets
Net assets / equity¥56.6bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥22.1bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥18.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥22.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.4bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥6.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥828m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥122m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥596m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥835m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥633m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥33.352023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥10.662023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.412022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥62.942022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥25.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio39.8%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio41.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio40.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥1.3bn
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥29m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥1.3bn
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥615m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2023-04-01 → 2023-09-30¥6.6bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2023-04-01 → 2023-09-30¥6.6bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2023-04-01 → 2023-09-30¥27m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2023-04-01 → 2023-09-30¥794m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2023-04-01 → 2023-09-30¥263m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥530m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2023-04-01 → 2023-09-30¥33m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2023-04-01 → 2023-09-30¥31.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2023-04-01 → 2023-09-30¥31.4bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥283m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2023-04-01 → 2023-09-30¥581m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2023-04-01 → 2023-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2023-04-01 → 2023-09-30¥106m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2023-04-01 → 2023-09-30¥100.0bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2023-04-01 → 2023-09-30¥95.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2023-04-01 → 2023-09-30¥502m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥142.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥135.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥6.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.9bn
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥30m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥1.6bn
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥910m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥6.7bn
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30−¥40m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥848m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥217m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥631m
jpcrp040300-q2r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥20m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥33.0bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥32.7bn
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥251m
jpcrp040300-q2r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥777m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥172m
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-09-30¥92.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-09-30¥88.0bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.5bn
jpcrp040300-q2r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-09-30¥627m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥136.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥129.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥7.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 545
ItemContextValueUnit
Provision for bonusesPrior1YearInstant982000000JPY
Provision for bonusesCurrentQuarterInstant1072000000JPY
Provision for directors bonusesPrior1YearInstant138000000JPY
Provision for directors bonusesCurrentQuarterInstant59000000JPY
Other clPrior1YearInstant2347000000JPY
Other clCurrentQuarterInstant2379000000JPY
Current liabilitiesPrior1YearInstant77584000000JPY
Current liabilitiesCurrentQuarterInstant85693000000JPY
Long term loans payablePrior1YearInstant14000000JPY
Long term loans payableCurrentQuarterInstant13000000JPY
Deferred tax liabilitiesPrior1YearInstant1457000000JPY
Deferred tax liabilitiesCurrentQuarterInstant1740000000JPY
Deferred tax liabilities for land revaluationPrior1YearInstant120000000JPY
Deferred tax liabilities for land revaluationCurrentQuarterInstant120000000JPY
Net defined benefit liabilityPrior1YearInstant350000000JPY
Net defined benefit liabilityCurrentQuarterInstant334000000JPY
Long term accounts payable otherPrior1YearInstant396000000JPY
Long term accounts payable otherCurrentQuarterInstant446000000JPY
Asset retirement obligations nclPrior1YearInstant337000000JPY
Asset retirement obligations nclCurrentQuarterInstant339000000JPY
Other nclPrior1YearInstant232000000JPY
Other nclCurrentQuarterInstant234000000JPY
Noncurrent liabilitiesPrior1YearInstant2910000000JPY
Noncurrent liabilitiesCurrentQuarterInstant3230000000JPY
LiabilitiesPrior1YearInstant80494000000JPY
LiabilitiesCurrentQuarterInstant88923000000JPY
Capital stockPrior1YearInstant1000000000JPY
Capital stockCurrentQuarterInstant1000000000JPY
Capital surplusPrior1YearInstant11821000000JPY
Capital surplusCurrentQuarterInstant11821000000JPY
Retained earningsPrior1YearInstant41315000000JPY
Retained earningsCurrentQuarterInstant41771000000JPY
Treasury stockPrior1YearInstant-1709000000JPY
Treasury stockCurrentQuarterInstant-1987000000JPY
Shareholders equityPrior1YearInstant52428000000JPY
Shareholders equityCurrentQuarterInstant52605000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5839000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6905000000JPY
Revaluation reserve for landPrior1YearInstant-742000000JPY
Revaluation reserve for landCurrentQuarterInstant-742000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-95000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-85000000JPY
Valuation and translation adjustmentsPrior1YearInstant5001000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant6078000000JPY
Non controlling interestsPrior1YearInstant13000000JPY
Non controlling interestsCurrentQuarterInstant13000000JPY
Net assetsPrior1YearInstant57443000000JPY
Net assetsCurrentQuarterInstant58697000000JPY
Liabilities and net assetsPrior1YearInstant137937000000JPY
Liabilities and net assetsCurrentQuarterInstant147621000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass